A clinical trial by a Tokyo-based venture company confirmed that transplanting cardiac muscle cell clusters created from iPS cells into patients with severe heart failure led to improvements. https://www.japantimes.co.jp/news/2025/12/13/japan/science-health/tokyo-startup-ips-heart-muscle/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #ips #stemcells #biotechnology
A Japanese research team has produced induced pluripotent stem, or iPS, cells safely and efficiently by adding artificially synthesized ribonucleic acid to human blood cells. https://www.japantimes.co.jp/news/2025/12/04/japan/science-health/ips-cells-blood/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #ips #stemcells #biotechnology #health #kyotouniversity
Inconsistent decisions of Japan's regional health bureaus on the approval of regenerative medicine plans have sparked an outcry among medical institutions. https://www.japantimes.co.jp/news/2025/07/28/japan/science-health/regional-differences-seen-in-regenerative-medicine-plan-approval/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #health #medicine #hospitals #stemcells